CIA Director William Burns tests positive for Covid after meeting with Biden, but is not considered a close contact

CIA Director William Burns tests positive for Covid after meeting with Biden, but is not considered a close contact


CIA Director Bill Burns testifies next to Director of National Intelligence Avril Haines during a House (Select) Intelligence Committee hearing on diversity in the intelligence community, on Capitol Hill in Washington, October 27, 2021.

Elizabeth Frantz | Reuters

WASHINGTON – CIA Director William Burns tested positive for Covid-19 on Thursday, the intelligence agency said.

Burns, who is fully vaccinated and boosted against Covid-19, last met with President Joe Biden on Wednesday morning during a “socially distanced meeting and was wearing an N-95 mask.”

“Their interaction is not considered close contact as defined by CDC guidance, and Director Burns is sharing the news of his positive test out of an abundance of transparency,” the intelligence agency wrote in a statement.

Burns will continue to perform his duties as CIA director but will work from home. He will return to the office following a negative test and after isolating for five days. The agency said that Burns has experienced mild symptoms.

Burns’ positive test follows two other virus cases within Biden’s orbit.

On Sunday, White House deputy press secretary Karine Jean-Pierre said she tested positive for Covid-19. Her positive test result came several days after White House press secretary Jen Psaki tested positive for the virus, which prevented her from traveling with Biden to Belgium and Poland.

Psaki said at the time that Biden was not considered a close contact following two socially distanced meetings.

Earlier this month, second gentleman Doug Emhoff tested positive for Covid-19. Following the positive test result, the White House said that Vice President Kamala Harris would skip a scheduled event “out of an abundance of caution.”

Biden, 79, received his fourth dose of the coronavirus vaccine on Wednesday.



Source

Eli Lilly and Novo Nordisk stocks fall as Trump says he wants 0 price for GLP-1s
Health

Eli Lilly and Novo Nordisk stocks fall as Trump says he wants $150 price for GLP-1s

Shares of Eli Lilly and Novo Nordisk dropped Friday, after President Donald Trump said his administration aims to cut the cost of brand name GLP-1 weight loss drugs to $150 per month, a fraction of their current list price. “In London, you’d buy a certain drug for $130 and even less than that … $88 […]

Read More
Trump announces efforts to expand access to IVF drugs
Health

Trump announces efforts to expand access to IVF drugs

U.S. President Donald Trump delivers remarks before signing an executive order on expanding access to IVF at his Mar-a-Lago resort on Feb. 18, 2025 in Palm Beach, Florida. Joe Raedle | Getty Images President Donald Trump on Thursday announced two new efforts to expand the availability of in vitro fertilization, the first concrete step from his […]

Read More
Genentech to sell flu pill directly to some consumers at a discount as Trump pressures drugmakers
Health

Genentech to sell flu pill directly to some consumers at a discount as Trump pressures drugmakers

A sign is posted in front of a Genentech office on June 12, 2025 in South San Francisco, California. Justin Sullivan | Getty Images Roche‘s Genentech on Thursday said it will sell its flu pill, Xofluza, directly to certain patients at a discount in a bid to expand access, becoming the latest company to wade […]

Read More